A systemic approach to improve patients adherence to medications

Size: px
Start display at page:

Download "A systemic approach to improve patients adherence to medications"

Transcription

1 A systemic approach to improve patients adherence to medications a Dutch initiative to create sustainable change Presentation for the Espacomp Congress 2009, Bangor, Wales. Marnix P.D. Westein, Phar. D., m.westein@winap.nl Royal Dutch Association for the Advancement of Pharmacy (KNMP) Tom Schoen, Senior Policy Advisor, The Federation of Patients and Consumer Organisations in the Netherlands (NPCF)

2 Overview of the presentation Facts and figures on medication adherence Survey comparing Dutch initiatives Changing our perspective A systemic approach Conclusion

3 Facts and Figures (1) Discontinuation percentage of chronic pharmacotherapy in the first year after start of the treatment (Netherlands 2002) Chronic Pharmacotherapy forever Report, Pharmo institute, 2002.

4 Facts and Figures (2) Adherence percentages found in Dutch Studies (2004) Factors related to adherence Report, NIVEL, 2004.

5 Internet survey of Dutch initiatives to improve adherence (2007) 41 initiatives were reported Examples: Monitoring drug prescriptions Distribution using a Medicationroll Communications checklists SMS reminder services Periodic Medication review Self management courses Patient Healthcare professional ICT Medicine

6 Internet survey of Dutch initiatives to improve adherence (2007) Comparing different actors different views on the problem different ways of measuring different solutions Results Unclear outcomes No widespread change

7 Changing our perspective on improving medication adherence Old perspective New perspective

8 Changing our perspective (2) Medication adherence is influenced by many variables which are highly interconnected many actors who act partly independent and act on multiple levels This generates outcomes which are difficult to measure and difficult to predict. In Health promotion research such a system is referred to as a complex or soft system.

9 A systemic approach is needed to create sustainable change Step 1: Investigate the problem Step 2: Develop a rich picture (of the actors, levels and their connections) Step 3: Extract main themes Step 4: Increase cooperation between actors Step 5: Develop and test potential solutions Step 6: Change practice D G Cramp, et al. Health Serv Man Res 2009; 22: Naaldenberg J, et al. Glob Health Prom 2009; 16; 39

10 Step 2: develop a rich picture (NPCF, 2008) Umbrella Organizations Pharm., Phys. and nurses Insurance companies Government Patient organizations Health care environment Nurse Pharmacist Physician ICT Pharmaceutical Companies Research & education Patient Medicine Social environment

11 Step 3: extract main themes (NPCF, 2008) 1. Improve communication between patients and healthcare professionals 2. Improve cooperation and information sharing between healthcare professionals 3. Develop and prescribe medicines which are easily adapted to patients daily routines 4. Tailor patients support to suit individual needs Tijd voor een beter gebruik van medicijnen, Westein NPCF 2008.

12 Step 4: Increase cooperation between actors Start of a national taskforce with members from 13 national organizations (KNMP/NPCF 2009) Task: to share visions on improving adherence and debate structure, meaning and power relations To improve cooperation and information sharing To identify and solve practical issues Result 2009: an overview of members activities in 2009 and plans for 2010

13 Examples of activities 2009 Outlines for a National research program on effective use of medicine Development of multidisciplinary healthcare guidelines for chronic diseases (e.g. diabetes, COPD) Increased pharmacy drug prescription monitoring Increased use of medicationroll Introduction of a yearly medication review for elderly Introduction of prescribing nurses

14 Step 5: Develop and test potential solutions (2010 ) Quantify goals Set priorities Standardize tools for measurement Develop and pilot interventions Measure results Integrate ICT-tools Increase evidence based practice

15 Systemic approach: conclusion Introduction to Pharmionics Vrijens & Urquhart, 2005 Journal of Antimicrobiol Chemotherapy

16 Initiatives on multiple levels MACRO Health policy MESO Center MICRO Patient-provider dyads PATIENT (De Geest et al., BRIGHT study protocol; McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q 1988;15(4): )

ESPACOMP PRE CONFERENCE WORKSHOP: Version

ESPACOMP PRE CONFERENCE WORKSHOP: Version ESPACOMP PRE CONFERENCE WORKSHOP: Version 1.11.13 Budapest, Hungary, 14 November 2013, 12.00 19.00 "Gobelin" room. Medication Adherence interventions: translating the state of art evidence in to your daily

More information

Blueprint Integrated Pilot Programs

Blueprint Integrated Pilot Programs Blueprint Integrated Pilot Programs Improving Access Improving Quality Improving Efficiency National Conference of State Legislatures December 10, 2008 Craig Jones MD Craig.jones@state.vt.us Health Care

More information

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional

More information

Caring for people with multimorbidity in Europe: an overview from the ICARE4EU project

Caring for people with multimorbidity in Europe: an overview from the ICARE4EU project Caring for people with multimorbidity in Europe: an overview from the ICARE4EU project Mieke Rijken (NIVEL) on behalf of the ICARE4EU consortium Multimorbidity: Prevalent, especially among older people

More information

97% 18% 2% self-employed/ freelancer/contractor. 30% part time. 27% Part time

97% 18% 2% self-employed/ freelancer/contractor. 30% part time. 27% Part time Pharmacy professionals - Overview Gender by population Male 39.6 Female 60.4 Age range by population Gender by population Male 10.3 Female 89.7 Age range by population 21.6 31.9 22.4 17.4 6.8 15.0 28.2

More information

Chapter 1. Scope of Clinical Pharmacy. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Chapter 1. Scope of Clinical Pharmacy. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. Chapter 1 Scope of Clinical Pharmacy M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. Objectives Describe how pharmacists can assist in your disease management programs

More information

Clinical Webinar: Integrated Pharmacy

Clinical Webinar: Integrated Pharmacy Clinical Webinar: Integrated Pharmacy Benjamin Gross, Pharm D, MBA, BCPS, BCACP, CDE, BC ADM, ASH CHC Associate Professor Director of Residency Programs Lipscomb University College of Pharmacy Objectives

More information

NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013

NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013 NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013 1. WHAT EXACTLY IS MEDICATION ADHERENCE? Adhering to medication means taking the medication as directed by a health care professional-

More information

Resilience Approach for Medical Residents

Resilience Approach for Medical Residents Resilience Approach for Medical Residents R.A. Bezemer and E.H. Bos TNO, P.O. Box 718, NL-2130 AS Hoofddorp, the Netherlands robert.bezemer@tno.nl Abstract. Medical residents are in a vulnerable position.

More information

Insights into Pharmacist Provided MTM Services-Present and Future

Insights into Pharmacist Provided MTM Services-Present and Future Insights into Pharmacist Provided MTM Services-Present and Future Anne Burns, RPh Vice President, Professional Affairs American Pharmacists Association Learning Objectives Describe the scope of MTM service

More information

Tackling the problem of obesity: the Dutch approach

Tackling the problem of obesity: the Dutch approach Tackling the problem of obesity: the Dutch approach Renders CM 1, Halberstadt J 2, Frenkel CS 3, Rosenmöller P 3, Seidell JC 1,2,4, Hirasing RA 1 1 Knowledge Center Overweight, EMGO Institute for Health

More information

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT

More information

Medication Adherence

Medication Adherence Medication Adherence Robert DiGregorio, PharmD, FNAP, BCACP Professor (Long Island University) Sr. Director, Pharmacy & Pharmacotherapy Services (TBHC) Chief, Pharmacotherapy Department of Internal Medicine

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines

More information

18 th ANNUAL ESPACOMP MEETING (November 20-22, 2014 in Lausanne, Switzerland)

18 th ANNUAL ESPACOMP MEETING (November 20-22, 2014 in Lausanne, Switzerland) 18 th ANNUAL ESPACOMP MEETING (November 20-22, 2014 in Lausanne, Switzerland) THURSDAY NOVEMBER 20 (pre-conference educational day) 09:00-09:30 Registration and welcome 09:30-17:00 Parallel sessions Workshop

More information

Strategic overview: NHS system

Strategic overview: NHS system Strategic overview: NHS system Dr Keith Ridge, Chief Pharmaceutical Officer 1 November 2016 A collaborative approach Five Year Forward View Oct 2014 NHS planning guidance, Dec 2015: Every health and care

More information

Introductie praktijonderzoek Developing indicators to measure pharmaceutical care across nations

Introductie praktijonderzoek Developing indicators to measure pharmaceutical care across nations Introductie praktijonderzoek WS 2 Developing indicators to measure pharmaceutical care across nations Martina Teichert Experts: Foppe van Mil, Martin Henman, Tommy Westerlund PCNE BLED 2017 Progam Sessions

More information

Medication Therapy Management

Medication Therapy Management Medication Therapy Management Presented by Sylvia Saade, PharmD Ghada Khoury, Pharm D, BCACP Objectives Describe the components of medication therapy management (MTM) programs Discuss the needs of MTM

More information

Pharmacy in 2020: Director s View

Pharmacy in 2020: Director s View In 2020: Grampian now has fewer community pharmacies than in 2012. The move to capitation based payments allied to the transfer of planning responsibility for pharmacy contracts to NHS Boards has led to

More information

Keenan Pharmacy Care Management (KPCM)

Keenan Pharmacy Care Management (KPCM) Keenan Pharmacy Care Management (KPCM) This program is an exclusive to KPS clients as an additional layer of pharmacy benefit management by engaging physicians and members directly to ensure that the best

More information

NHS community pharmacy advanced services Briefing for GP practices

NHS community pharmacy advanced services Briefing for GP practices NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the

More information

The Pharmacist Coalition for Health Reform

The Pharmacist Coalition for Health Reform 1 As Australian health professionals and policymakers grapple with the pressures and realities of caring for a growing community with changing needs, there s an opportunity to uncover better ways of using

More information

Disease State Management Clinics: A Pharmacist Perspective

Disease State Management Clinics: A Pharmacist Perspective Disease State Management Clinics: A Pharmacist Perspective Eva Berrios Colon, Pharm.D, MPH, BCPS Associate Professor, Touro College of Pharmacy Email: evb9001@nyp.org 5/12/11 The Brooklyn Hospital Center

More information

W e were aware that optimising medication management

W e were aware that optimising medication management 207 QUALITY IMPROVEMENT REPORT Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds M Fertleman, N Barnett, T Patel... See end of article for authors affiliations...

More information

Medido, a smart medication dispensing solution, shows high rates of medication adherence and potential to reduce cost of care.

Medido, a smart medication dispensing solution, shows high rates of medication adherence and potential to reduce cost of care. White Paper Medido, a smart medication dispensing solution, shows high rates of medication adherence and potential to reduce cost of care. A Philips Lifeline White Paper Tine Smits, Research Scientist,

More information

Medication Accuracy at Transitions in Care Let s start!

Medication Accuracy at Transitions in Care Let s start! Medication Accuracy at Transitions in Care Let s start! @PatVei Erica Van der Schrieck-De Loos MSc, Project leader WHO H5s NL CBO Dutch Institute for Healthcare Improvement EU Union Network PaSQ Med Rec

More information

Disclosures. Learning Objectives 4/26/2017. Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic

Disclosures. Learning Objectives 4/26/2017. Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic Impact of a Pilot Ambulatory Care Pharmacist in a Family Practice Clinic Taylor Sandvick, PharmD, PGY1 Pharmacy Resident St. Peter s Hospital, Helena, MT April 29, 2017 Disclosures 2 Financial: Nothing

More information

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Overview This standard describes the skills, knowledge and understanding required to demonstrate competence

More information

Tackling the challenge of non-adherence

Tackling the challenge of non-adherence Tackling the challenge of non-adherence 2 How is adherence defined? WHO definition: the extent to which a person s behaviour taking medication, following a diet and/or executing lifestyle changes corresponds

More information

GPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation

GPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation GPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation Background The General Pharmaceutical Council (GPhC) is

More information

MEDICATION THERAPY MANAGEMENT. MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT

MEDICATION THERAPY MANAGEMENT. MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT MEDICATION THERAPY MANAGEMENT Medication Therapy Management 1 $ 290 Billion Wasted in avoidable costs due

More information

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose.

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose. Transitions of Care Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital 1 The author has nothing to disclose. 2 Objectives Discuss current healthcare trends and the need for pharmacists in

More information

Safe & Sound: How to Prevent Medication Mishaps. A Family Caregiver Healthcare Education Program. A Who What Where Why When Tool Kit

Safe & Sound: How to Prevent Medication Mishaps. A Family Caregiver Healthcare Education Program. A Who What Where Why When Tool Kit Safe & Sound: How to Prevent Medication Mishaps A Family Caregiver Healthcare Education Program A Who What Where Why When Tool Kit National Family Caregivers Association www.thefamilycaregiver.org 800/896-3650

More information

By: Jacqueline Kayler DeBrew, MSN, RN, CS, Beth E. Barba, PhD, RN, and Anita S. Tesh, EdD, RN

By: Jacqueline Kayler DeBrew, MSN, RN, CS, Beth E. Barba, PhD, RN, and Anita S. Tesh, EdD, RN Assessing Medication Knowledge and Practices of Older Adults By: Jacqueline Kayler DeBrew, MSN, RN, CS, Beth E. Barba, PhD, RN, and Anita S. Tesh, EdD, RN DeBrew, J., Barba, B. E., & Tesh, A. S. (1998).

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on Ways and Means Subcommittee on Health

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on Ways and Means Subcommittee on Health Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on Ways and Means Subcommittee on Health Hearing on: The President s and Other Bipartisan Proposals

More information

Jan Taco te Gussinklo. On behalf of the Dutch Association for ehealth (NVEH), The Netherlands

Jan Taco te Gussinklo. On behalf of the Dutch Association for ehealth (NVEH), The Netherlands Jan Taco te Gussinklo On behalf of the Dutch Association for ehealth (NVEH), The Netherlands Trends in ehealth: The e-patient More patients want to take more control of their own health. (Mobile) internet

More information

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem

More information

Literature review: pharmaceutical services for prisoners

Literature review: pharmaceutical services for prisoners Author: Rosemary Allgeier, Principal Pharmacist in Public Health. Date: 08 October 2012 Version: 1a Publication and distribution: NHS Wales (intranet and internet) Public Health Wales (intranet and internet)

More information

The Merits of a Robot: a Dutch Experience

The Merits of a Robot: a Dutch Experience The Merits of a Robot: a Dutch Experience Mark P. Mobach University of Groningen, Faculty of Management and Organization, Groningen, The Netherlands Received August 24, 2006; Revised November 6, 2006;

More information

2018 Medication Therapy Management Program Information

2018 Medication Therapy Management Program Information 2018 Medication Therapy Management Program Information What is the Medication Therapy Management Program? The Medication Therapy Management Program is a service for members with multiple health conditions

More information

ehealth in caring for people with multimorbidity in European countries

ehealth in caring for people with multimorbidity in European countries ehealth in caring for people with multimorbidity in European countries Francesco Barbabella (INRCA, Linnaeus University) on behalf of the ICARE4EU consortium Policy Issue New opportunities enabled by the

More information

Expanding Your Pharmacist Team

Expanding Your Pharmacist Team CALIFORNIA QUALITY COLLABORATIVE CHANGE PACKAGE Expanding Your Pharmacist Team Improving Medication Adherence and Beyond August 2017 TABLE OF CONTENTS Introduction and Purpose 1 The CQC Approach to Addressing

More information

March 3, i. Medication Reconciliation Post Discharge (Part C) (p. 79)

March 3, i. Medication Reconciliation Post Discharge (Part C) (p. 79) March 3, 2017 [Submitted electronically to AdvanceNotice2018@cms.hhs.gov] Centers for Medicare & Medicaid Services U.S. Dept. of Health & Human Services Attention: CMS-4159-P P.O. Box 8013 Baltimore, MD

More information

Medicines Optimisation Strategy

Medicines Optimisation Strategy Medicines Optimisation Strategy 2014-2017 Contents Section Page 1 Foreword 3 2 Strategic Principles for Medicines Optimisation 4 3 Introduction 4 4 Trust Vision and Values 5 5 Strategy Development 5 6

More information

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 DISCLOSURE STATEMENT I have nothing to disclose regarding

More information

Community Pharmacy Multi-compartment Compliance Aids Audit

Community Pharmacy Multi-compartment Compliance Aids Audit Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must

More information

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

CLINICAL AUDIT. The Safe and Effective Use of Warfarin CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.

More information

Provider Information Guide Complex Care and Condition Care Overview

Provider Information Guide Complex Care and Condition Care Overview Complex and Overview Introduction Complex and are essential components of Passport Health Plan s (Passport) Coordination services, which are used to support the practitioner-patient relationship and plan

More information

Cumbria Rural Health Forum Alison Marshall 1, Tom Bell 2, J-Lyn Khoo 1

Cumbria Rural Health Forum Alison Marshall 1, Tom Bell 2, J-Lyn Khoo 1 Cumbria Rural Health Forum Alison Marshall 1, Tom Bell 2, J-Lyn Khoo 1 1 University of Cumbria, 2 Cumbria Partnership NHS Foundation Trust International Digital Health and Care Congress, King s Fund, London,

More information

Passport Advantage (HMO SNP) Model of Care Training (Providers)

Passport Advantage (HMO SNP) Model of Care Training (Providers) Passport Advantage (HMO SNP) Model of Care Training (Providers) 2018 Passport Advantage (HMO SNP) is an HMO Special Needs plan with a Medicare contract and an agreement with the Kentucky Department for

More information

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI Transition of Care Practices Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI Objectives Pharmacist 1. Describe transition of care opportunities 2. Explain ways to use pharmacist extenders

More information

A pharmacist s guide to Pharmacy Services compensation

A pharmacist s guide to Pharmacy Services compensation Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2017/10) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription

More information

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist Curriculum vitae PERSONAL INFORMATION Gyorgyi Fodor WORK EXPERIENCE September 2011 Present Pharmacovigilance assessor National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Benefit/risk assessment,

More information

A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators

A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators Martirosyan et al. BMC Health Services Research 2012, 12:191 RESEARCH ARTICLE Open Access A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators Liana Martirosyan

More information

T O G E T H E R W E M A K E A G R E A T T E A M. January 6, 2014

T O G E T H E R W E M A K E A G R E A T T E A M. January 6, 2014 7272 Wisconsin Avenue Bethesda, Maryland 20814 301-657-3000 Fax: 301-664-8877 www.ashp.org Richard Kronick, Ph.D. Director, Agency for Healthcare Research and Quality Agency for Healthcare Research and

More information

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part

More information

JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population

JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population Use of Epidemiologic Studies to Examine Safety in Diverse Populations Judy A. Staffa, Ph.D, R.Ph. Director

More information

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs HEALTH SERVICES RESEARCH FUND HEALTH CARE AND PROMOTION FUND Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

More information

Improving Access in Infusion Therapy

Improving Access in Infusion Therapy Improving Access in Infusion Therapy Timmi Anne Boesken, MHA, CPhT Medication Access Services Coordinator Kathryn Clark McKinney, PharmD, MS, BCPS, FACHE Director of Pharmacy Services Michelle Dusing Wiest,

More information

Bringing the Clinical Mindset to the Retail Pharmacist

Bringing the Clinical Mindset to the Retail Pharmacist Bringing the Clinical Mindset to the Retail Pharmacist Sarah Griffin, Pharm.D. Harding University College of Pharmacy White County Medical Center Objectives Describe challenging situations faced by pharmacists

More information

Driving the value of health care through integration. Kaiser Permanente All Rights Reserved.

Driving the value of health care through integration. Kaiser Permanente All Rights Reserved. Driving the value of health care through integration February 13, 2012 Kaiser Permanente 2010-2011. All Rights Reserved. 1 Today s agenda How Kaiser Permanente is transforming care How we re updating our

More information

Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine

Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia Clinical Pharmacy Research Group (CLIP) Anne Spinewine 1 04.10.2011 WBI- UCL Research activities

More information

Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services

Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services Professor Djenane Ramalho de Oliveira, PhD Director, Centro de Estudos em Atenção Farmacêutica (CEAF)

More information

Medication Adherence: Strategies for Improving Outcomes

Medication Adherence: Strategies for Improving Outcomes Medication Adherence: Strategies for Improving Outcomes Thursday, June 16, 2016, 12:00 p.m. to 1:00 p.m. Andrea H. Williams, RPh, MBA President, RX CONSULTANTS LLC, Wilmington, DE EDUCATIONAL OBJECTIVES

More information

B. Douglas Hoey, RPh, MBA. CEO National Community Pharmacists Association

B. Douglas Hoey, RPh, MBA. CEO National Community Pharmacists Association Presenter B. Douglas Hoey, RPh, MBA CEO National Community Pharmacists Association www.ncpanet.org Follow the Conversation Online Follow NCPA on Twitter @commpharmacy for live coverage of today s Web event

More information

BEHAVIOUR CHANGE HTA,

BEHAVIOUR CHANGE HTA, BEHAVIOUR CHANGE HTA, clinical protocols and guidelines. How to engage health professionals, patients, prescribers and the community? Aine Heaney NPS Medicinewise IDENTIFYING BARRIERS TO EVIDENCE UPTAKE

More information

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

CONSULTANT PHARMACIST INSPECTION LAW REVIEW CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted

More information

arizona health net a better decision sm Putting you at the center of everything we do.

arizona health net a better decision sm Putting you at the center of everything we do. arizona health net a better decision sm Putting you at the center of everything we do. Nothing s more important than your health. When you re healthy, you want to stay healthy. When you re sick or have

More information

FIP STATEMENT OF POLICY Pharmacy: Gateway to Care

FIP STATEMENT OF POLICY Pharmacy: Gateway to Care Preamble Knowledge, prevention and management of disease has changed dramatically in recent decades. In addition to the responsibility of governments to provide the fundamental right of health, citizens

More information

Reducing the High Cost of Patient Non-Adherence:

Reducing the High Cost of Patient Non-Adherence: Reducing the High Cost of Patient Non-Adherence: Navigating the Optimal Journey to Improved Outcomes By Amy Parke, Vice President Integrated Marketing Communications, Ashfield Healthcare Communications

More information

Course Co ordinator: Trudi Aspden BPharm, PhD. Extension 83893

Course Co ordinator: Trudi Aspden BPharm, PhD. Extension 83893 Please SWITCH OFF your phone before each lecture Course Co ordinator: Trudi Aspden BPharm, PhD Desk 51, School of Pharmacy, Level 3, Building 505 Extension 83893 e mail t.aspden@auckland.ac.nz ac nz Pharmacy

More information

MEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS

MEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS MEDS TO BEDS AND CARE MANAGEMENT MEDICATION ASSESSMENT TOOLKIT: FOR HOSPITAL TEAM AND PHARMACISTS Implementation Toolkit Last Updated: 02/2018 OneCity Health Services 199 Water Street, 31st Floor, New

More information

The added value of pharmacists in the care of frail older patients

The added value of pharmacists in the care of frail older patients The added value of pharmacists in the care of frail older patients Anne Spinewine MPharm, MSc, PhD Université catholique de Louvain, Belgium Louvain Drug Research Institute and CHU Mont Godinne Godinne

More information

Prescribing in primary care

Prescribing in primary care Prescribing in primary care Understanding what shapes GPs prescribing choices and how might these be changed Amanda Scoggins, Jan Tiessen, Tom Ling, Lila Rabinovich Prescribing in primary care Understanding

More information

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document

More information

The European network evaluation of the PHAR QA framework of competences for...

The European network evaluation of the PHAR QA framework of competences for... The European network evaluation of the PHAR QA framework of competences for... The PHAR QA ( Quality assurance in European pharmacy education and training ) funded by the European Commission, will produce

More information

Community Pharmacy in 2016/17 and beyond

Community Pharmacy in 2016/17 and beyond Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,

More information

Use of Health Information Technology to Reduce Health Risk

Use of Health Information Technology to Reduce Health Risk Use of Health Information Technology to Reduce Health Risk Sandra M. Foote Senior Advisor, Chronic Care Improvement Centers for Medicare & Medicaid Services September 9, 2005 The MHS Challenge Develop

More information

CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW

CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW Diplomate: CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW A. INFORMATION MANAGEMENT 1. Does your practice currently use an electronic medical record system? Yes No 2. If Yes, how long has the

More information

Expanding an innovative Bedside Concierge program

Expanding an innovative Bedside Concierge program E3 (EFFECTIVENESS, EFFICIENCY, EXCELLENCE IN HEALTHCARE) GRANT CASE STUDY ALL IN FOR GOOD Expanding an innovative Bedside Concierge program Patients get prescriptions delivered bedside, and can consult

More information

What is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012

What is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012 MTM: Successfully Engaging Eligible Patients Objectives Explain What MTM is as defined by the Medicare Modernization Act Describe examples of MTM services Recognize the various entities who pay for MTM

More information

JOB DESCRIPTION. Responsible to: Deputy Director of Pharmacy & Aseptics Accountable Pharmacist

JOB DESCRIPTION. Responsible to: Deputy Director of Pharmacy & Aseptics Accountable Pharmacist JOB DESCRIPTION 1. JOB IDENTIFICATION Job Title: Deputy Aseptics Accountable and Clinical Pharmacist B7 (Specialist Clinical Pharmacist B7 ) Responsible to: Deputy Director of Pharmacy & Aseptics Accountable

More information

PHARMACY (PHAR) PHAR 534. Foundations III. 1.5 Hour.

PHARMACY (PHAR) PHAR 534. Foundations III. 1.5 Hour. Pharmacy (PHAR) 1 PHARMACY (PHAR) PHAR 201. Introduction to Pharmacy. 1 Hour. Semester course; 1 lecture hour. 1 credit. Open to undergraduate students with an interest in pursuing pharmacy as a career.

More information

PRESCRIPTION FOR HEALTH A COMPREHENSIVE WEB SITE TO HELP YOU IMPROVE PATIENTS MEDICATION ADHERENCE

PRESCRIPTION FOR HEALTH A COMPREHENSIVE WEB SITE TO HELP YOU IMPROVE PATIENTS MEDICATION ADHERENCE PRESCRIPTION FOR HEALTH A COMPREHENSIVE WEB SITE TO HELP YOU IMPROVE PATIENTS MEDICATION ADHERENCE MEDICATION ADHERENCE Medication adherence can be defined as how well a patient s* medication behavior

More information

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals One Year Later Sean Egan Head of Healthcare Regulation Health Information and Quality Authority Presentation outline Recap on the

More information

NHS Prescription Services CPAF Screening Questionnaire 2018/19

NHS Prescription Services CPAF Screening Questionnaire 2018/19 NHS Prescription Services CPAF Screening Questionnaire 08/9 Important Information about this Document This is a reference copy of the Community Pharmacy Assurance Framework Screening Questionnaire, the

More information

JOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area

JOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area JOB DESCRIPTION JOB TITLE: LOCATION: ACCOUNTABLE TO: RESPONSIBLE TO: PROFESSIONALLY RESPONSIBLE TO: LEAD PRACTICE BASED PHARMACIST Designated GP Practice in Federation area Federation Chair Practice Prescribing

More information

Quality Medication Use in Aboriginal Communities

Quality Medication Use in Aboriginal Communities Quality Medication Use in Aboriginal Communities Lance Emerson, Kathy Bell, Roland Manning 5th National Rural Health Conference Adelaide, South Australia, 14-17th March 1999 Lance Emerson Proceedings Quality

More information

Pharmacy Department, Borders General Hospital

Pharmacy Department, Borders General Hospital 1. JOB IDENTIFICATION Job Title: Responsible to: Department & Base: Clinical Pharmacist BGH Lead Clinical Pharmacist Pharmacy Department, Borders General Hospital Date this JD written/updated: 25.4.14

More information

NORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE

NORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE NORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE Northern Ireland - Who are we? Challenge faced medicines optimisation Strategic approach to upscaling good practice Upscaling

More information

JOB DESCRIPTION. BGH Pharmacy

JOB DESCRIPTION. BGH Pharmacy JOB DESCRIPTION 1. JOB DETAILS Job Title: Responsible to: Department & Base: Senior Clinical Pharmacy Technician (Prescription for Excellence) Lead Pharmacist, Primary and Community Care BGH Pharmacy Date

More information

Pharmacist (Palliative Care) December 2014 Page 1

Pharmacist (Palliative Care) December 2014 Page 1 Job Profile Job Title: Department: Main Location: Hospice Palliative Care Pharmacist 7 NHS (8SRC) Less than full time(0.8) Full time equivalent around 36,300 Head of Clinical Services 1. Main Purpose of

More information

MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview

MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview Today s Speaker Dan Rodriguez, RPh, BPharm Sr. Associate Network Performance OutcomesMTM Learning Objectives - Define Medication

More information

4. Hospital and community pharmacies

4. Hospital and community pharmacies 4. Hospital and community pharmacies As FIP is the international professional organisation of pharmacists, this paper emphasises the role of the pharmacist in ensuring and increasing patient safety. The

More information

Patient Care: Case Study in EHR Implementation. With Help From Monkeys, Mice, and Penguins. Tom Goodwin, MHA MIT Medical Cambridge, MA March 2007

Patient Care: Case Study in EHR Implementation. With Help From Monkeys, Mice, and Penguins. Tom Goodwin, MHA MIT Medical Cambridge, MA March 2007 Using Information Technology to Drive Patient Care: Case Study in EHR Implementation With Help From Monkeys, Mice, and Penguins Tom Goodwin, MHA MIT Medical Cambridge, MA March 2007 MIT Medical Staff 122

More information

ehealth in the Netherlands Policies, developments and status of cross-enterprise information exchange in Dutch healthcare

ehealth in the Netherlands Policies, developments and status of cross-enterprise information exchange in Dutch healthcare ehealth in the Netherlands Policies, developments and status of cross-enterprise information exchange in Dutch healthcare ehealth in the Netherlands Policies, developments and status of cross-enterprise

More information

Evaluation of Pharmacy Delivery Models

Evaluation of Pharmacy Delivery Models Evaluation of Pharmacy Delivery Models As Required By House Bill 1, 84th Legislature, Regular Session, 2015 (Article II, Health and Human Services Commission, Rider 83) Health and Human Services Commission

More information

Effective team working to improve diabetes care in older people

Effective team working to improve diabetes care in older people Article Effective team working to improve diabetes care in older people Joy Williams An ageing population means that diabetes healthcare professionals are often caring for older people with many comorbidities

More information

Zukunftsperspektiven der Qualitatssicherung in Deutschland

Zukunftsperspektiven der Qualitatssicherung in Deutschland Zukunftsperspektiven der Qualitatssicherung in Deutschland Future of Quality Improvement in Germany Prof. Richard Grol Fragmentation in quality assessment and improvement Integration of initiatives and

More information

The Search for Best Practice in Medication Reconciliation

The Search for Best Practice in Medication Reconciliation The Search for Best Practice in Medication Reconciliation National Medicines Forum November 2013 Marie Kehoe O Sullivan Director, Safety and Quality Improvement HIQA HIQA Collaboration with IHI Open School

More information